As evaluated in IARC Monographs Volumes 1-100A

This list contains all agents evaluated as being in Group 2B. Where appropriate, chemical abstract numbers are given [in square brackets]. For details of the evaluation, the relevant Monograph should be consulted (volume number given in round brackets, followed by year of publication of latest evaluation). Use a free-text search to find a particular compound.

Group 2B: Possibly carcinogenic to humans (248)

Agents and groups of agents

A-a-C (2-Amino-9H-pyrido[2,3-b]indole) [26148-68-5] (Vol. 40, Suppl. 7; 1987)

Acetaldehyde [75-07-0] (Vol. 36, Suppl. 7, Vol. 71; 1999)

Acetamide [60-35-5] (Vol. 7, Suppl. 7, Vol. 71; 1999)

Acrylonitrile [107-13-1] (Vol. 71; 1999)

AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide] [3688-53-7] (Vol.31, Suppl. 7; 1987)

Aflatoxin M1 [6795-23-9] (Vol. 56; 1993)

para-Aminoazobenzene [60-09-3] (Vol. 8, Suppl. 7; 1987)

ortho-Aminoazotoluene [97-56-3] (Vol. 8, Suppl. 7; 1987)

2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole [712-68-5] (Vol. 7, Suppl. 7; 1987)

Amsacrine [51264-14-3] (Vol. 76; 2000)

ortho-Anisidine [90-04-0] (Vol. 73; 1999)

Antimony trioxide [1309-64-4] (Vol. 47; 1989)

Aramite® [140-57-8] (Vol. 5, Suppl. 7; 1987)

Auramine [492-80-8] (technical-grade) (Vol. 1, Suppl. 7, Vol. 99; in preparation)

Azaserine [115-02-6] (Vol. 10, Suppl. 7; 1987)

Aziridine [151-56-4] (Vol. 9, Suppl. 7, Vol. 71; 1999)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from other relevant data)

Benz[j]aceanthrylene [202-33-5] (Vol. 92; in preparation)
(NB: Overall evaluation upgraded from 3 to 2B with supporting mechanistic and other relevant data)

Benz[a]anthracene [56-55-3] (Vol. 32, Suppl. 7, Vol. 92; in preparation)

Benzo[b]fluoranthene [205-99-2] (Vol. 32, Suppl. 7, Vol. 92; in preparation)

Benzo[j]fluoranthene [205-82-3] (Vol. 32, Suppl. 7, Vol. 92; in preparation)

Benzo[k]fluoranthene [207-08-9] (Vol. 32, Suppl. 7, Vol. 92; in preparation)

Benzofuran [271-89-6] (Vol. 63; 1995)

Benzo[c]phenanthrene [195-19-7] (Vol. 32, Suppl. 7, Vol. 92; in preparation)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from other relevant data)

Benzyl violet 4B [1694-09-3] (Vol. 16, Suppl. 7; 1987)

2,2-Bis(bromomethyl)propane-1,3-diol [3296-90-0] (Vol. 77; 2000)

Bleomycins [11056-06-7] (Vol. 26, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from other relevant data)

Bracken fern (Vol. 40, Suppl. 7; 1987)

Bromodichloromethane [75-27-4] (Vol. 52, Vol. 71; 1999)

Butylated hydroxyanisole (BHA) [25013-16-5] (Vol. 40, Suppl. 7;1987)

b-Butyrolactone [3068-88-0] (Vol. 11, Suppl. 7, Vol. 71; 1999)

Caffeic acid [331-39-5] (Vol. 56; 1993)

Carbon black [1333-86-4] (Vol. 65, Vol. 93; in preparation)

Carbon tetrachloride [56-23-5] (Vol. 20, Suppl. 7, Vol. 71; 1999)

Catechol [120-80-9] (Vol. 15, Suppl. 7, Vol. 71; 1999)

Chlordane [57-74-9] (Vol. 79; 2001)

Chlordecone (Kepone) [143-50-0] (Vol. 20, Suppl. 7; 1987)

Chlorendic acid [115-28-6] (Vol. 48; 1990)

para-Chloroaniline [106-47-8] (Vol. 57; 1993)

3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone [77439-76-0] (Vol. 84; 2004)

Chloroform [67-66-3] (Vol. 73; 1999)

1-Chloro-2-methylpropene [513-37-1] (Vol. 63; 1995)

[Chlorophenols: see Polychlorophenols]

Chlorophenoxy herbicides (Vol. 41, Suppl. 7; 1987)

4-Chloro-ortho-phenylenediamine [95-83-0] (Vol. 27, Suppl.7; 1987)

Chloroprene [126-99-8] (Vol. 71; 1999)

Chlorothalonil [1897-45-6] (Vol. 73; 1999)

Chrysene [218-01-9] (Vol. 32, Suppl. 7, Vol. 92; in preparation)

CI Acid Red 114 [6459-94-5] (Vol. 57; 1993)

CI Basic Red 9 [569-61-9] (Vol. 57, Vol. 99; in preparation)

CI Direct Blue 15 [2429-74-5] (Vol. 57; 1993)

Citrus Red No. 2 [6358-53-8] (Vol. 8, Suppl. 7; 1987)

Cobalt [7440-48-4] and cobalt compounds (Vol. 52; 1991)
(NB: Evaluated as a group)

Cobalt sulfate [10026-24-1] and other soluble cobalt(II) salts (Vol. 86; 2006)

para-Cresidine [120-71-8] (Vol. 27, Suppl. 7; 1987)

Cycasin [14901-08-7] (Vol. 10, Suppl. 7; 1987)

Dacarbazine [4342-03-4] (Vol. 26, Suppl. 7; 1987)

Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone) [117-10-2] (Vol. 50; 1990)

Daunomycin [20830-81-3] (Vol. 10, Suppl. 7; 1987)

DDT [p,p'-DDT, 50-29-3] (Vol. 53; 1991)

N,N'-Diacetylbenzidine [613-35-4] (Vol. 16, Suppl.7; 1987)

2,4-Diaminoanisole [615-05-4] (Vol. 79; 2001)

4,4'-Diaminodiphenyl ether [101-80-4] (Vol. 29, Suppl. 7; 1987)

2,4-Diaminotoluene [95-80-7] (Vol. 16, Suppl. 7; 1987)

Dibenz[a,h]acridine [226-36-8] (Vol. 32, Suppl. 7; 1987)

Dibenz[a,j]acridine [224-42-0] (Vol. 32, Suppl. 7; 1987)

7H-Dibenzo[c,g]carbazole [194-59-2] (Vol. 32, Suppl.7; 1987)

Dibenzo[a,h]pyrene [189-64-0] (Vol. 32, Suppl. 7, Vol. 92; in preparation)

Dibenzo[a,i]pyrene [189-55-9] (Vol. 32, Suppl. 7, Vol. 92; in preparation)

1,2-Dibromo-3-chloropropane [96-12-8] (Vol. 20, Suppl. 7, Vol. 71; 1999)

2,3-Dibromopropan-1-ol [96-13-9] (Vol. 77; 2000)

Dichloroacetic acid [79-43-6] (Vol. 84; 2004)

para-Dichlorobenzene [106-46-7] (Vol. 73; 1999)

3,3'-Dichlorobenzidine [91-94-1] (Vol. 29, Suppl. 7; 1987)

3,3'-Dichloro-4,4'-diaminodiphenyl ether [28434-86-8] (Vol. 16,Suppl. 7; 1987)

1,2-Dichloroethane [107-06-2] (Vol. 20, Suppl. 7, Vol. 71; 1999)

Dichloromethane (methylene chloride) [75-09-2] (Vol. 71; 1999)

1,3-Dichloropropene [542-75-6] (technical-grade) (Vol. 41, Suppl.7, Vol. 71; 1999)

Dichlorvos [62-73-7] (Vol. 53; 1991)

Diepoxybutane [1464-53-5] (Vol. 11, Suppl. 7, Vol. 71, Vol. 97; 2008)

1,2-Diethylhydrazine [1615-80-1] (Vol. 4, Suppl. 7, Vol. 71; 1999)

Diglycidyl resorcinol ether [101-90-6] (Vol. 36, Suppl. 7, Vol. 71; 1999)

Dihydrosafrole [94-58-6] (Vol. 10, Suppl. 7; 1987)

Diisopropyl sulfate [2973-10-6] (Vol. 54, Vol. 71; 1999)

3,3'-Dimethoxybenzidine (ortho-Dianisidine) [119-90-4] (Vol. 4, Suppl. 7; 1987)

para-Dimethylaminoazobenzene [60-11-7] (Vol. 8, Suppl. 7; 1987)

trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)-vinyl]-1,3,4-oxadiazole [25962-77-0]
(Vol. 7, Suppl. 7; 1987)

2,6-Dimethylaniline (2,6-Xylidine) [87-62-7] (Vol. 57; 1993)

3,3'-Dimethylbenzidine (ortho-Tolidine) [119-93-7] (Vol.1, Suppl. 7; 1987)

1,1-Dimethylhydrazine [57-14-7] (Vol. 4, Suppl. 7, Vol. 71; 1999)

3,7-Dinitrofluoranthene [105735-71-5] (Vol. 65; 1996)

3,9-Dinitrofluoranthene [22506-53-2] (Vol. 65; 1996)

1,6-Dinitropyrene [42397-64-8] (Vol. 46; 1989)

1,8-Dinitropyrene [42397-65-9] (Vol. 46; 1989)

2,4-Dinitrotoluene [121-14-2] (Vol. 65; 1996)

2,6-Dinitrotoluene [606-20-2] (Vol. 65; 1996)

1,4-Dioxane [123-91-1] (Vol. 11, Suppl. 7, Vol. 71; 1999)

Disperse Blue 1 [2475-45-8] (Vol. 48; 1990)

1,2-Epoxybutane [106-88-7] (Vol. 47, Vol. 71; 1999)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from other relevant data)

Ethyl acrylate [140-88-5] (Vol. 39, Suppl. 7, Vol. 71; 1999)

Ethylbenzene [100-41-4] (Vol. 77; 2000)

Ethyl methanesulfonate [62-50-0] (Vol. 7, Suppl. 7; 1987)

[Foreign bodies: see Surgical implants and other foreign bodies]

2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole [3570-75-0] (Vol. 7, Suppl. 7; 1987)

Fumonisin B₁ [116355-83-0] (Vol. 82; 2002)

Furan [110-00-9] (Vol. 63; 1995)

Glu-P-1 (2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole) [67730-11-4] (Vol. 40, Suppl. 7; 1987)

Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole)[67730-10-3] (Vol. 40, Suppl. 7; 1987)

Glycidaldehyde [765-34-4] (Vol. 11, Suppl. 7, Vol. 71; 1999)

Griseofulvin [126-07-8] (Vol. 79; 2001)

HC Blue No. 1 [2784-94-3] (Vol. 57; 1993)

Heptachlor [76-44-8] (Vol. 79; 2001)

Hexachlorobenzene [118-74-1] (Vol. 79; 2001)

Hexachloroethane [67-72-1] (Vol. 73; 1999)

Hexachlorocyclohexanes (Vol. 20, Suppl. 7; 1987)

Hexamethylphosphoramide [680-31-9] (Vol. 15, Suppl. 7, Vol. 71; 1999)

Human immunodeficiency virus type 2 (infection with) (Vol. 67; 1996)

Human papillomavirus types 6 and 11 (Vol. 90; 2007)

Human papillomavirus genus beta (some types) (Vol. 90; 2007)

Hydrazine [302-01-2] (Vol. 4, Suppl. 7, Vol. 71; 1999)

1-Hydroxyanthraquinone [129-43-1] (Vol. 82; 2002)

Indeno[1,2,3-cd]pyrene [193-39-5] (Vol. 32, Suppl. 7, Vol. 92; in preparation)

Iron-dextran complex [9004-66-4] (Vol. 2, Suppl. 7; 1987)

Isoprene [78-79-5] (Vol. 60, Vol. 71; 1999)

Lasiocarpine [303-34-4] (Vol. 10, Suppl. 7; 1987)

Lead [7439-92-1] (Vol. 23, Suppl. 7; 1987)

Magenta (mixtures composed of C.I. Basic Red 9 [569-61-9], methyl fuchsin [632-99-5], dimethyl fuchsin [26261-57-4] or trimethyl fuchsin [3248-91-7]) (Vol. 57, Vol. 99; in preparation)

Magnetic fields (extremely low-frequency) (Vol. 80; 2002)

MeA-a-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole) [68006-83-7] (Vol. 40, Suppl. 7; 1987)

Medroxyprogesterone acetate [71-58-9] (Vol. 21, Suppl. 7; 1987)

MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) [77094-11-2] (Vol. 56; 1993)

MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) [77500-04-0] (Vol. 56; 1993)

Merphalan [531-76-0] (Vol. 9, Suppl. 7; 1987)

2-Methylaziridine (Propyleneimine) [75-55-8] (Vol. 9, Suppl. 7, Vol. 71; 1999)

Methylazoxymethanol acetate [592-62-1] (Vol. 10, Suppl. 7; 1987)

5-Methylchrysene [3697-24-3] (Vol. 32, Suppl. 7, Vol. 92; in preparation)

4,4'-Methylene bis(2-methylaniline) [838-88-0] (Vol. 4, Suppl.7; 1987)

4,4'-Methylenedianiline [101-77-9] (Vol. 39, Suppl. 7; 1987)

Methylmercury compounds (Vol. 58; 1993)
(NB: Evaluated as a group)

2-Methyl-1-nitroanthraquinone [129-15-7] (uncertain purity) (Vol.27, Suppl. 7; 1987)

N-Methyl-N-nitrosourethane [615-53-2] (Vol. 4, Suppl.7; 1987)

Methylthiouracil [56-04-2] (Vol. 79; 2001)

Metronidazole [443-48-1] (Vol. 13, Suppl. 7; 1987)

Michler's base [4,4'-methylenebis(N,N-dimethyl)benzenamine] [101-61-1] (Vol. 27, Suppl. 7, Vol. 99; in preparation)

Michler's ketone [4,4'-bis(dimethylamino)benzophenone] [90-94-8] (Vol. 99; in preparation)

Microcystin-LR [101043-37-2] (Vol. 94; in preparation)
(NB: Overall evaluation upgraded from 3 to 2B based on mechanistic and other relevant data)

Mirex [2385-85-5] (Vol. 20, Suppl. 7; 1987)

Mitomycin C [50-07-7] (Vol. 10, Suppl. 7; 1987)

Mitoxantrone [65271-80-9] (Vol. 76; 2000)

Monocrotaline [315-22-0] (Vol. 10, Suppl. 7; 1987)

5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)amino]-2-oxazolidinone [3795-88-8] (Vol. 7, Suppl. 7; 1987)

Nafenopin [3771-19-5] (Vol. 24, Suppl. 7; 1987)

Naphthalene [91-20-3] (Vol. 82; 2002)

Nickel, metallic [7440-02-0] and alloys (Vol. 49; 1990)

Niridazole [61-57-4] (Vol. 13, Suppl. 7; 1987)

Nitrilotriacetic acid [139-13-9] and its salts (Vol. 73; 1999)
(NB: Evaluated as a group)

5-Nitroacenaphthene [602-87-9] (Vol. 16, Suppl. 7; 1987)

2-Nitroanisole [91-23-6] (Vol. 65; 1996)

Nitrobenzene [98-95-3] (Vol. 65; 1996)

6-Nitrochrysene [7496-02-8] (Vol. 46; 1989)

Nitrofen [1836-75-5] (technical-grade) (Vol. 30, Suppl. 7; 1987)

2-Nitrofluorene [607-57-8] (Vol. 46; 1989)

1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone [555-84-0] (Vol.7, Suppl. 7; 1987)

N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide [531-82-8] (Vol. 7, Suppl. 7; 1987)

Nitrogen mustard N-oxide [126-85-2] (Vol. 9, Suppl. 7;1987)

Nitromethane [75-52-5] (Vol. 77; 2000)

2-Nitropropane [79-46-9] (Vol. 29, Suppl. 7, Vol. 71; 1999)

1-Nitropyrene [5522-43-0] (Vol. 46; 1989)

4-Nitropyrene [57835-92-4] (Vol. 46; 1989)

N-Nitrosodi-n-butylamine [924-16-3] (Vol. 17, Suppl.7; 1987)

N-Nitrosodiethanolamine [1116-54-7] (Vol. 17, Suppl. 7, Vol. 77; 2000)

N-Nitrosodi-n-propylamine [621-64-7] (Vol. 17, Suppl.7; 1987)

3-(N-Nitrosomethylamino)propionitrile [60153-49-3] (Vol. 85; 2004)

N-Nitrosomethylethylamine [10595-95-6] (Vol. 17, Suppl. 7; 1987)

N-Nitrosomethylvinylamine [4549-40-0] (Vol. 17, Suppl. 7; 1987)

N-Nitrosomorpholine [59-89-2] (Vol. 17, Suppl. 7; 1987)

N-Nitrosopiperidine [100-75-4] (Vol. 17, Suppl. 7; 1987)

N-Nitrosopyrrolidine [930-55-2] (Vol. 17, Suppl. 7; 1987)

N-Nitrososarcosine [13256-22-9] (Vol. 17, Suppl. 7; 1987)

Ochratoxin A [303-47-9] (Vol. 56; 1993)

Oil Orange SS [2646-17-5] (Vol. 8, Suppl. 7; 1987)

Oxazepam [604-75-1] (Vol. 66; 1996)

Palygorskite (attapulgite) [12174-11-7] (long fibres, > 5 micrometres) (Vol. 68; 1997)

Panfuran S [794-93-4] (containing dihydroxymethylfuratrizine)
(Vol. 24, Suppl. 7; 1987)

Phenazopyridine hydrochloride [136-40-3] (Vol. 24, Suppl. 7; 1987)

Phenobarbital [50-06-6] (Vol. 79; 2001)

Phenolphthalein [77-09-8] (Vol. 76; 2000)

Phenoxybenzamine hydrochloride [63-92-3] (Vol. 24, Suppl. 7; 1987)

Phenyl glycidyl ether [122-60-1] (Vol. 47, Vol. 71; 1999)

Phenytoin [57-41-0] (Vol. 66; 1996)

PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) [105650-23-5] (Vol. 56; 1993)

Polychlorophenols and their sodium salts (mixed exposures) (Vol. 41, Suppl. 7, Vol. 53, Vol. 71; 1999)

Ponceau MX [3761-53-3] (Vol. 8, Suppl. 7; 1987)

Ponceau 3R [3564-09-8] (Vol. 8, Suppl. 7; 1987)

Potassium bromate [7758-01-2] (Vol. 73; 1999)

Progestins (Suppl. 7; 1987)

Progestogen-only contraceptives (Vol. 72; 1999)

1,3-Propane sultone [1120-71-4] (Vol. 4, Suppl. 7, Vol. 71; 1999)

b-Propiolactone [57-57-8] (Vol. 4, Suppl. 7, Vol. 71; 1999)

Propylene oxide [75-56-9] (Vol. 60; 1994)

Propylthiouracil [51-52-5] (Vol. 79; 2001)

Refractory ceramic fibres (Vol. 43, Vol. 81; 2002)

Riddelliine [23246-96-0] (Vol. 10, Suppl. 7, Vol. 82; 2002)

Safrole [94-59-7] (Vol. 10, Suppl. 7; 1987)

Schistosoma japonicum (infection with) (Vol. 61; 1994)

Sodium ortho-phenylphenate [132-27-4] (Vol. 73; 1999)

Special-purpose fibres such as E-glass and '475' glass fibres (Vol. 81; 2002)

Sterigmatocystin [10048-13-2] (Vol. 10, Suppl. 7; 1987)

Streptozotocin [18883-66-4] (Vol. 17, Suppl. 7; 1987)

Styrene [100-42-5] (Vol. 60, 82; 2002)

Sulfallate [95-06-7] (Vol. 30, Suppl. 7; 1987)

Surgical implants and other foreign bodies (Vol. 74; 1999):
- Polymeric implants prepared as thin smooth film (with the exception of poly(glycolic acid))
- Metallic implants prepared as thin smooth films
- Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium and 7% iron

Tetrafluoroethylene [116-14-3] (Vol. 19, Suppl. 7, Vol. 71; 1999)

Tetranitromethane [509-14-8] (Vol. 65; 1996)

Thioacetamide [62-55-5] (Vol. 7, Suppl. 7; 1987)

4,4'-Thiodianiline [139-65-1] (Vol. 27, Suppl. 7; 1987)

Titanium dioxide [13463-67-7] (Vol. 47, Vol. 93; in preparation)

Thiouracil [141-90-2] (Vol. 79; 2001)

Toluene diisocyanates [26471-62-5] (Vol. 39, Suppl. 7, Vol. 71; 1999)

Trichlormethine (Trimustine hydrochloride) [817-09-4] (Vol. 50; 1990)

Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole)[62450-06-0] (Vol. 31, Suppl. 7; 1987)

Trp-P-2 (3-Amino-1-methyl-5H-pyrido[4,3-b]indole)[62450-07-1] (Vol. 31, Suppl. 7; 1987)

Trypan blue [72-57-1] (Vol. 8, Suppl. 7; 1987)

Uracil mustard [66-75-1] (Vol. 9, Suppl. 7; 1987)

Vanadium pentoxide [1314-62-1] (Vol. 86; 2006)

Vinyl acetate [108-05-4] (Vol. 63; 1995)

4-Vinylcyclohexene [100-40-3] (Vol. 60; 1994)

4-Vinylcyclohexene diepoxide [106-87-6] (Vol. 60; 1994)

Zalcitabine [7481-89-2] (Vol. 76; 2000)

Zidovudine (AZT) [30516-87-1] (Vol. 76; 2000)

Mixtures

Bitumens [8052-42-4], extracts of steam-refined and air-refined (Vol. 35, Suppl. 7; 1987)

Carrageenan [9000-07-1], degraded (Vol. 31, Suppl. 7; 1987)

Chlorinated paraffins of average carbon chain length C12 and average degree of chlorination approximately 60% (Vol. 48; 1990)

Coffee (urinary bladder) (Vol. 51; 1991)
(NB: There is some evidence of an inverse relationship between coffee drinking and cancer of the large bowel; coffee drinking could not be classified as to its carcinogenicity to other organs)

Diesel fuel, marine (Vol. 45; 1989)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from other relevant data)

Engine exhaust, gasoline (Vol. 46; 1989)

Fuel oils, residual (heavy) (Vol. 45; 1989)

Gasoline (Vol. 45; 1989)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from other relevant data)

Pickled vegetables (traditional in Asia) (Vol. 56; 1993)

Polybrominated biphenyls [Firemaster BP-6, 59536-65-1] (Vol. 41, Suppl. 7; 1987)

Toxaphene (Polychlorinated camphenes) [8001-35-2] (Vol. 79; 2001)

Toxins derived from Fusarium moniliforme: fumonisin B1 and B2 and fusarin C (Vol. 56; 1993)

Welding fumes (Vol. 49; 1990)

Exposure circumstances

Carpentry and joinery (Vol. 25, Suppl. 7; 1987)

Cobalt metal without tungsten carbide (Vol. 86; 2006)

Dry cleaning (occupational exposures in) (Vol. 63; 1995)

Firefighter (occupational exposure as a) (Vol. 98; in preparation)

Printing processes (occupational exposures in) (Vol. 65; 1996)

Talc-based body powder (perineal use of) (Vol. 93; in preparation)

Textile manufacturing industry (work in) (Vol. 48; 1990)

Last updated: 28 March 2008